Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study of ABSK021 to Assess the Efficacy and Safety in Patients With Tenosynovial Giant Cell Tumor (TANGENT)

Link : TBD
Status : RECRUITING
Population : PVNS/TGCT
Description : Emactuzumab vs. placebo
PI : A. Razak
Centers Opened : PMH
Phase : III
IIST/Pharma : Pharma